Should EGFR TKI Therapy be Continued Beyond Progression? episode artwork

EPISODE · Oct 26, 2015 · 2 MIN

Should EGFR TKI Therapy be Continued Beyond Progression?

from GRACEcast · host cancerGRACE Meetings

Dr. Greg Riely, medical oncologist from MSKCC, discusses the controversial question of whether patients should continue on an oral EGFR tyrosine kinase inhibitor after progression.

Episode metadata supplied by the publisher feed · Published Oct 26, 2015

Embed this episode

NOW PLAYING

Should EGFR TKI Therapy be Continued Beyond Progression?

0:00 2:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on October 26, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!